PER 2.50% 8.2¢ percheron therapeutics limited

FDA approves Sareptas Srp901 for the whole population, page-5

  1. 90 Posts.
    lightbulb Created with Sketch. 9
    @itsagas you are allowed to be wrong but in my opinion you are not allowed to keep switching opinions to whatever soundbites you need that will may PER look like they are going to succeed.

    We have watched you continually post about how good its going to be for PER when Sarepta's application fails and now it hasnt failed. It doesn't matter. If it doesn't matter, than it was never going to help, so what is it.

    We all want PER to win and you are welcome to rejoice when it does.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.0¢ 8.2¢ 8.0¢ $216.5K 2.688M

Buyers (Bids)

No. Vol. Price($)
5 317461 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 285087 1
View Market Depth
Last trade - 16.10pm 26/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.